Estrogens and epilepsy: Why are we so excited?

Neuroscientist

Volumn 13, Issue 1, 2007, Pages 77-88

  Velíšková, Jana ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Estrogens; Hippocampal damage; Neuronal activity; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; LETROZOLE; NEUROTRANSMITTER; ORAL CONTRACEPTIVE AGENT; PHENOBARBITAL; PHENYTOIN; PROGESTERONE; TOPIRAMATE;

ADULTHOOD; BRAIN DAMAGE; CELL MATURATION; DEVELOPMENT; DRUG ANTAGONISM; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; EPILEPSY; EXCITABILITY; HIPPOCAMPUS; HORMONE ACTION; HUMAN; MENOPAUSE; MENSTRUAL CYCLE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; NUTRITION; OVARY CYCLE; PREGNANCY; PRIORITY JOURNAL; REVIEW; SEIZURE; TEMPORAL LOBE EPILEPSY;

ANIMALS; ANTICONVULSANTS; CONTRACEPTIVE AGENTS; EPILEPSY; ESTROGENS; FEMALE; HIPPOCAMPUS; HORMONE REPLACEMENT THERAPY; HUMANS; MENSTRUAL CYCLE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS;

EID: 33845976322     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858406295827     Document Type: Review

References (84)

1. Backstrom T. 1976. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand 54: 321 - 347.
2. Behr J, Lyson KJ, Mody I. 1998. Enhanced propagation of epilepti-form activity through the kindled dentate gyrus. J Neurophysiol 79: 1726 - 1732.
3. Ben-Ari Y, Tremblay E, Riche D, Ghilini G, Naquet R. 1981. Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience 6: 1361 - 1391.
4. Briellmann RS, Berkovic SF, Jackson GD. 2000. Men may be more vulnerable to seizure-associated brain damage. Neurology 55: 1479 - 1485.
5. Buterbaugh GG, Hudson GM. 1991. Estradiol replacement to female rats facilitates dorsal hippocampal but not ventral hippocampal kindled seizure acquisition. Exp Neurol 111: 55 - 64.
6. Dawson R Jr, Wallace DR. 1992. Kainic acid-induced seizures in aged rats: neurochemical correlates. Brain Res Bull 29: 459 - 468.
7. Diamantopoulos N, Crumrine PK. 1986. The effect of puberty on course of epilepsy. Arch Neurol 43: 873 - 876.
8. Drew JH, Bayly J, Beischer NA. 1983. Prospective follow-up of growth retarded infants and of those from pregnancies complicated by low oestriol excretion - 7 years. Aust N Z J Obstet Gynaecol 23: 150 - 154.
9. Edwards HE, Burnham WM, Mendonca A, Bowlby DA, MacLusky NJ. 1999. Steroid hormones affect limbic afterdischarge thresholds and kindling rates in adult female rats. Brain Res 838: 136 - 150.
10. El Bahh B, Balosso S, Hamilton T, Herzog H, Beck-Sickinger AG, Sperk G, and others. 2005. The anti-epileptic actions of neuropep-tide Y in the hippocampus are mediated by Y2 and not Y5 receptors. Eur J Neurosci 22: 1417 - 1430.
11. Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI. 2002. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16: 70 - 84.
12. Foldvary-Schaefer N, Falcone T. 2003. Catamenial epilepsy: pathophysiology, diagnosis, and management. Neurology 61: S2 - S15.
13. Freund TF, Buzsaki G. 1996. Interneurons of the hippocampus. Hippocampus 6: 347 - 470.
14. Frye CA, Rhodes ME. 2005. Estrogen-priming can enhance progesterone's anti-seizure effects in part by increasing hippocampal levels of allopregnanolone. Pharmacol Biochem Behav 81: 907 - 916.
15. Galanopoulou AS, Alm EM, Velíšková J. 2003. Estradiol reduces seizure-induced hippocampal injury in ovariectomized female but not in male rats. Neurosci Lett 342: 201 - 205.
16. Garcia-Segura LM, Azcoitia I, DonCarlos LL. 2001. Neuroprotection by estradiol. Prog Neurobiol 63: 29 - 60.
17. Gevorkyan ES, Nazaryan KB, Kostanyan AA. 1989. Modifying effect of estradiol and progesterone on epileptic activity of the rat brain. Neurosci Behav Physiol 19: 412 - 415.
18. Giorgi FS, Velíšková J, Chudomel O, Kyrozis A, Moshé SL. 2007. The role of substantia nigra pars reticulata in modulating clonic seizures is determined by testosterone levels during the immediate postnatal period. Neurobiol Dis 25: 73 - 79.
19. Gowers WR. 1881. Epilepsy and other chronic convulsive diseases. London: J. A. Churchill.
20. Gu Q, Korach KS, Moss RL. 1999. Rapid action of 17beta-estradiol on kainate-induced currents in hippocampal neurons lacking intracellular estrogen receptors. Endocrinology 140: 660 - 666.
21. Harden C, MacLusky NJ. 2005. Aromatase inhibitors as add-on treatment for men with epilepsy. Expert Rev Neurother 5: 123 - 127.
22. Harden CL, Pulver MC, Ravdin L, Jacobs AR. 1999. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 40: 1402 - 1407.
23. Haut SR, Velíšková J, Moshé SL. 2004. Susceptibility of immature and adult brains to seizure effects. Lancet Neurol 3: 608 - 617.
24. Hayashi T, Ishikawa T, Yamada K, Kuzuya M, Naito M, Hidaka H, and others. 1994. Biphasic effect of estrogen on neuronal constitutive nitric oxide synthase via Ca(2+)-calmodulin dependent mechanism. Biochem Biophys Res Commun 203: 1013 - 1019.
25. Herzog AG. 1988. Clomiphene therapy in epileptic women with menstrual disorders. Neurology 38: 432 - 434.
26. Herzog AG. 1995. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 45: 1660 - 1662.
27. Herzog AG, Harden CL, Liporace J, Pennell P, Schomer DL, Sperling M, and others. 2004. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann Neurol 56: 431 - 434.
28. Herzog AG, Klein P, Ransil BJ. 1997. Three patterns of catamenial epilepsy. Epilepsia 38: 1082 - 1088.
29. Hoffman GE, Moore N, Fiskum G, Murphy AZ. 2003. Ovarian steroid modulation of seizure severity and hippocampal cell death after kainic acid treatment. Exp Neurol 182: 124 - 134.
30. Hom AC, Buterbaugh GG. 1986. Estrogen alters the acquisition of seizures kindled by repeated amygdala stimulations or pentylenetetrazol administration in ovariectomized female rats. Epilepsia 27: 103 - 108.
31. Jacono JJ, Robertson JMD. 1987. The effects of estrogen, progesterone, and ionized calcium on seizures during the menstrual cycle of epileptic women. Epilepsia 28: 571 - 577.
32. Klein P, van Passel-Clark LM, Pezzullo JC. 2003. Onset of epilepsy at the time of menarche. Neurology 60: 495 - 497.
33. Lavaque E, Sierra A, Azcoitia I, Garcia-Segura LM. 2006. Steroidogenic acute regulatory protein in the brain. Neuroscience 138: 741 - 747.
34. Logothetis J, Harner R, Morrel F, Torres F. 1959. The role of estrogens in catamenial exacerbation of epilepsy. Neurology (Minneap) 9: 352 - 360.
35. Malyala A, Kelly MJ, Ronnekleiv OK. 2005. Estrogen modulation of hypothalamic neurons: activation of multiple signaling pathways and gene expression changes. Steroids 70: 397 - 406.
36. Manev H, Pericic D. 1987. Sex difference in the turnover of GABA in the rat substantia nigra. J Neural Transm 70: 321 - 328.
37. Manthey D, Behl C. 2006. From structural biochemistry to expression profiling: neuroprotective activities of estrogen. Neuroscience 138: 845 - 850.
38. Marcus EM, Watson CW, Goldman PL. 1966. Effects of steroids on cerebral electrical activity: epileptogenic effects of conjugated estrogens and related compounds in the cat and rabbit. Arch Neurol 15: 521 - 532.
39. Mathern GW, Babb TL, Armstrong DL. 1997. Hippocampal sclerosis. In: Engel JJ, Pedley TA, editors. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven. p 133 - 155.
40. Matthews J, Gustafsson JA. 2003. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv 3: 281 - 292.
41. Mattson RH, Cramer JA, Darney PD, Naftolin F. 1986. Use of oral contraceptives by women with epilepsy. JAMA 256: 238 - 240.
42. McDermott JL, Liu B, Dluzen DE. 1994. Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice. Exp Neurol 125: 306 - 311.
43. McEwen B. 2002. Estrogen actions throughout the brain. Recent Prog Horm Res 57: 357 - 384.
44. Mermelstein PG, Becker JB, Surmeier DJ. 1996. Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J Neurosci 16: 595 - 604.
45. Mhyre AJ, Dorsa DM. 2006. Estrogen activates rapid signaling in the brain: role of estrogen receptor alpha and estrogen receptor beta in neurons and glia. Neuroscience 138: 851 - 858.
46. Morrell MJ. 1997. Hormones, reproductive health, and epilepsy. In: Wyllie E, editor. The treatment of epilepsy: principles and practice. Baltimore: Williams & Wilkins. p 179 - 187.
47. Nadal A, Ropero AB, Laribi O, Maillet M, Fuentes E, Soria B. 2000. Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor alpha and estrogen receptor beta [in process citation]. Proc Natl Acad Sci USA 97: 11603 - 11608.
48. Nakamura NH, Rosell DR, Akama KT, McEwen BS. 2005. Estrogen and ovariectomy regulate mRNA and protein of glutamic acid decarboxylases and cation-chloride cotransporters in the adult rat hippocampus. Neuroendocrinology 80: 308 - 323.
49. Neal-Perry GS, Zeevalk GD, Santoro NF, Etgen AM. 2005. Attenuation of preoptic area glutamate release correlates with reduced luteinizing hormone secretion in middle-aged female rats. Endocrinology 146: 4331 - 4339.
50. Nicoletti F, Speciale C, Sortino MA, Summa G, Caruso G, Patti F, and others. 1985. Comparative effects of estradiol benzoate, the antiestrogen clomiphene citrate, and the progestin medroxyprogesterone acetate on kainic acid-induced seizures in male and female rats. Epilepsia 26: 252 - 257.
51. Otani K. 1985. Risk factors for the increased seizure frequency during pregnancy and puerperium. Folia Psychiatr Neurol Jpn 39: 33 - 41.
52. Pack AM, Morrell MJ. 2002. Treatment of women with epilepsy. Semin Neurol 22: 289 - 298.
53. Peebles CT, McAuley JW, Moore JL, Malone HJ, Reeves AL. 2000. Hormone replacement therapy in a postmenopausal woman with epilepsy. Ann Pharmacother 34: 1028 - 1031.
54. Pongrac JL, Gibbs RB, Defranco DB. 2004. Estrogen-mediated regulation of cholinergic expression in basal forebrain neurons requires extracellular-signal- regulated kinase activity. Neuroscience 124: 809 - 816.
55. Rao BR. 1998. Isolation and characterization of an estrogen binding protein which may integrate the plethora of estrogenic actions in non-reproductive organs. J Steroid Biochem Mol Biol 65: 3 - 41.
56. Reibel S, Andre V, Chassagnon S, Andre G, Marescaux C, Nehlig A, and others. 2000. Neuroprotective effects of chronic estradiol benzoate treatment on hippocampal cell loss induced by status epilepticus in the female rat. Neurosci Lett 281: 79 - 82.
57. Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ, 3rd. 2006. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 7: 821-828.
58. Rudick CN, Woolley CS. 2001. Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J Neurosci 21: 6532 - 6543.
59. Saberi M, Pourgholami MH, Jorjani M. 2001. The acute effects of estradiol benzoate on amygdala-kindled seizures in male rats. Brain Res 891: 1 - 6.
60. Savic I, Engel J Jr. 1998. Sex differences in patients with mesial temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 65: 910 - 912.
61. Scharfman HE, Goodman JH, Rigoulot MA, Berger RE, Walling SG, Mercurio TC, and others. 2005. Seizure susceptibility in intact and ovariectomized female rats treated with the convulsant pilocarpine. Exp Neurol 196: 73 - 86.
62. Schmidt D, Canger R, Avanzini G, Battino D, Cusi C, Beck-Mannagetta G, and others. 1983. Change of seizure frequency in pregnant epileptic women. J Neurol Neurosurg Psychiatry 46: 751 - 755.
63. Schultz-Krohn WA, Thompson J, Holmes GL. 1986. Effect of systemic estrogen on seizure susceptibility in the immature animal. Epilepsia 27: 538 - 541.
64. Schumacher M, Coirini H, McEwen BS. 1989. Regulation of high-affinity GABAA receptors in the dorsal hippocampus by estradiol and progesterone. Brain Res 487: 178 - 183.
65. Schwartz-Giblin S, Korotzer A, Pfaff DW. 1989. Steroid hormone effects on picrotoxin-induced seizures in female and male rats. Brain Res 476: 240 - 247.
66. Shinnar S, Moshé SL. 1991. Age specificity of seizure expression in genetic epilepsies. In: Anderson VE, Hauser WA, Leppik IE, Noebels JL, Rich SS, editors. Genetic strategies in epilepsy research. New York: Raven. p 69 - 85
67. Silva AP, Pinheiro PS, Carvalho AP, Carvalho CM, Jakobsen B, Zimmer J, and others. 2003. Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures. FASEB J 17: 1118 - 1120.
68. Sperk G, Marksteiner J, Gruber B, Bellmann R, Mahata M, Ortler M. 1992. Functional changes in neuropeptide Y-and somatostatincontaining neurons induced by limbic seizures in the rat. Neuroscience 50: 831 - 846.
69. Stitt SL, Kinnard RJ. 1968. The effect of certain progestins and estrogen on the threshold of electrically-induced seizure patterns. Neurology 18: 213 - 216.
70. Swann JW, Al-Noori S, Jiang M, Lee CL. 2000. Spine loss and other dendritic abnormalities in epilepsy. Hippocampus 10: 617 - 625.
71. Terasawa E, Timiras PS. 1968. Electrical activity during the estrous cycle of the rat: cyclic changes in limbic structures. Endocrinology 83: 207 - 216.
72. Teyler TJ, Vardaris RM, Lewis D, Rawitch AB. 1980. Gonadal steroids: Effects on excitability of hippocampal pyramidal cells. Science 209: 1017 - 1019.
73. Timiras PS. 1969. Role of hormones in development of seizures. In: Jasper HH, editor. Basic mechanisms of the epilepsies. Boston: Little, Brown. p 727 - 736.
74. Toran-Allerand CD. 2004. Minireview: a plethora of estrogen receptors in the brain: where will it end? Endocrinology 145: 1069 - 1074.
75. Toran-Allerand CD, Singh M, Setalo G Jr. 1999. Novel mechanisms of estrogen action in the brain: new players in an old story. Front Neuroendocrinol 20: 97 - 121.
76. Valente SG, Naffah-Mazzacoratti MG, Pereira M, Silva I, Santos NF, Baracat EC, and others. 2002. Castration in female rats modifies the development of the pilocarpine model of epilepsy. Epilepsy Res 49: 181 - 188.
77. Velíšek L, Velíšková J. 2002. Estrogen treatment protects GABA(B) inhibition in the dentate gyrus of female rats after kainic acidinduced status epilepticus. Epilepsia 43 (Suppl 5). 146 - 151.
78. Velíšek L, Velíšková J, Etgen AM, Stanton PK, Moshe SL. 1999. Region-specific modulation of limbic seizure susceptibility by ovarian steroids. Brain Res 842: 132 - 138.
79. Velíšková J. 2006. The role of estrogens in seizures and epilepsy: the bad guys or the good guys? Neuroscience 138: 837 - 844.
80. Velíšková J, Moshé SL. 2001. Sexual dimorphism and developmental regulation of substantia nigra function. Ann Neurol 50: 596 - 601.
81. Velíšková J, Velíšek L, Galanopoulou AS, Sperber EF. 2000. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia 41: S30 - S35.
82. Weaver CE Jr, Park-Chung M, Gibbs TT, Farb DH. 1997. 17beta-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res 761: 338 - 341.
83. Whitehead R, McNeil E. 1952. The therapeutic effects of estrogenic hormone preparations in certain cases of idiopathic epilepsy and in migraine. Am J Psychiatry 21: 1275 - 1288.
84. Woolley CS, Weiland NG, McEwen BS, Schwartzkroin PA. 1997. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J Neurosci 17: 1848 - 1859.